New York State Common Retirement Fund
SER icon

New York State Common Retirement Fund’s Serina Therapeutics SER Stock Holding History

New York State Common Retirement Fund’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-198
Closed -$6K – 3295
2020
Q1 		$6K Hold
198
– – ﹤0.01% 3162
2019
Q4 		$13K Hold
198
– – ﹤0.01% 3186
2019
Q3 		$14K Hold
198
– – ﹤0.01% 3211
2019
Q2 		$26K Hold
198
– – ﹤0.01% 3218
2019
Q1 		$28K Hold
198
– – ﹤0.01% 3118
2018
Q4 		$21K Buy
+198
New +$25.2K ﹤0.01% 3156

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

New York State Common Retirement Fund's SER Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Serina Therapeutics (SER) in Q2 2020, closing a stake of 198 shares — an estimated $6K sold.

New York State Common Retirement Fund first reported a position in SER in Q4 2018 and held it in 6 quarters. The position peaked at $28K in Q1 2019. 48 funds tracked by Wall St. Rank hold SER as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Serina Therapeutics position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 198 Serina Therapeutics shares in Q2 2020, an estimated $6K.
  • New York State Common Retirement Fund first reported a position in Serina Therapeutics in Q4 2018 and held it in 6 quarters.
  • New York State Common Retirement Fund's Serina Therapeutics position peaked at $28K in Q1 2019.
  • 48 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.